INBP · Integrated Biopharma Inc
Market Cap
$5.59M
Shares
31.06M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-20 | — | |
| 8-K | 2026-07-02 | 2026-06-30 | |
| 8-K | 2026-05-08 | — | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| 8-K | 2026-04-15 | 2026-04-14 | |
| 8-K | 2026-02-18 | 2026-02-17 | |
| 8-K | 2026-02-11 | — | |
| 10-Q | 2026-02-11 | 2025-12-31 | |
| 8-K | 2025-12-01 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| DEF 14A | 2025-10-28 | — | |
| 10-K | 2025-09-23 | 2025-06-30 | |
| 8-K | 2025-09-23 | — | |
| 8-K | 2025-05-14 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-04-24 | — | |
| 8-K | 2025-04-21 | 2025-04-15 | |
| 10-Q | 2025-02-13 | 2024-12-31 | |
| 8-K | 2025-02-13 | — | |
| 8-K | 2024-12-02 | — | |
| 8-K | 2024-11-14 | 2024-11-13 | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| DEF 14A | 2024-10-28 | — | |
| 8-K | 2024-09-23 | 2024-09-20 | |
| 10-K | 2024-09-20 | 2024-06-30 | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| 8-K | 2024-05-10 | — | |
| 10-Q | 2024-02-12 | 2023-12-31 | |
| 8-K | 2024-02-12 | — | |
| 8-K | 2023-11-27 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-09 | — | |
| DEF 14A | 2023-10-27 | — | |
| 8-K | 2023-09-15 | — | |
| 10-K | 2023-09-15 | 2023-06-30 | |
| 10-Q | 2023-05-11 | 2023-03-31 | |
| 8-K | 2023-05-11 | — | |
| 8-K | 2023-03-21 | 2023-03-20 | |
| 8-K | 2023-03-17 | 2023-03-16 | |
| 8-K | 2023-02-10 | — | |
| 10-Q | 2023-02-10 | 2022-12-31 | |
| 8-K | 2022-12-06 | 2022-12-01 | |
| 8-K | 2022-11-28 | — | |
| 8-K/A | 2022-11-14 | 2022-11-10 | |
| 8-K | 2022-11-14 | 2022-11-10 | |
| 10-Q | 2022-11-10 | 2022-09-30 | |
| DEF 14A | 2022-10-27 | 2022-11-28 | |
| 8-K | 2022-10-24 | 2022-10-21 | |
| 8-K | 2022-09-14 | 2022-09-13 |
Showing 1–50 of 81 filings